Goldman Sachs Group Inc Vera Therapeutics, Inc. Transaction History
Goldman Sachs Group Inc
- $596 Billion
- Q1 2025
A detailed history of Goldman Sachs Group Inc transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 505,918 shares of VERA stock, worth $10.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
505,918
Previous 505,918
-0.0%
Holding current value
$10.6 Million
Previous $12.2 Million
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding VERA
# of Institutions
195Shares Held
63.9MCall Options Held
723KPut Options Held
186K-
Avoro Capital Advisors LLC New York, NY5.7MShares$120 Million2.22% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.75MShares$99.7 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$70 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$62 Million19.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.92MShares$61.2 Million0.0% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $567M
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...